NexgenRx Inc.

NexgenRx Inc.

October 01, 2009 14:14 ET

NexgenRx Announces Issuance of Shares in Payment of Quarterly Debenture Interest

TORONTO, ONTARIO--(Marketwire - Oct. 1, 2009) - NEXGENRX INC. ("NexgenRx" or the "Company") (TSX VENTURE:NXG) announces that it has issued 181,321 common shares, at a price of $0.22 per share, in lieu of cash payment of interest accrued on the $2,000,000 of convertible debentures issued in October 2007. The foregoing shares are subject to hold periods in accordance with applicable securities laws, which will expire on January 31, 2010. It is at the discretion of the Corporation to issue shares in lieu of cash as payment of interest on the convertible debentures.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    (416) 695-3393 x 801
    (647) 722-2920 (FAX)
    NexgenRx Inc.
    Taba Merrikh
    VP, Finance and CFO
    (416) 695-3393 x 502
    (647) 722-7335 (FAX)